Biotech | August 06, 2021
Mark W. Womack is the new CEO of Stelis Biopharma
He will be stationed at the company HQ in Bengaluru, India
He will be stationed at the company HQ in Bengaluru, India
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
Complementary business models are the reason for the acquisition
This deal makes Meddo, one of the largest health-tech players in India
With the acquisition of these further shares, TWPL has now become company's subsidiary.
Broadens company’s oncology platform of Targeted Alpha Therapies (TATs)
Aurobindo has one of the most enduring generics ecosystems among peers
India sales grew 23.5% YoY with consolidation of Wockhardt products
Acquisition of A&C expands Aceto’s Western manufacturing footprint
ICICI Securities expects Hemmo to grow its revenue at a CAGR of 30.0% over FY21E-FY23E
Subscribe To Our Newsletter & Stay Updated
